eShowcase: Liquent InSight v. 3.5

March 1, 2007

Applied Clinical Trials

Applied Clinical Trials, Applied Clinical Trials-03-01-2007, Volume 0, Issue 0

Dual-purpose package allows submission in both paper and electronic formats

Dual-purpose package allows submission in both paper and electronic formats

Thomson Scientific (Philadelphia, PA, and London, UK) recently released the latest version of its regulatory compliance tool, InSight Publisher version 3.5. The latest iteration enables pharmaceutical companies to create, manage, and publish regulatory submissions in both paper and electronic form using a single software application, potentially saving critical time in the drug development process.

Around the world, regulatory authorities increasingly prefer the electronic format, yet they still require a paper version. With Liquent InSight version 3.5, life science professionals can produce both from a single assembly, using the same thin-client application integrated with the rest of the InSight software suite. Since it is built on the same platform as InSight Manager, which offers registration management and submission tracking capabilities, the entire platform is highly adaptable to different organizational processes and designs.

Thomson Scientific, (215) 386-0100, www.liquent.com

Related Content:

News